Landenberg, PA, United States of America

Eddy W Yue

This inventor holds 69 USPTO granted patents and 31 published patent applications, plus 6 CIPO patents and 16 EPO patents, primarily in PI3K Inhibitors (CPC class C07D). Top assignees: Incyte Corporation, Incyte Holdings Corporation, Bristol-Myers Squibb Pharma Company. Active years: 2001-2026.

USPTO Granted Patents = 69 (Patent Applications = 31)

% Patents Active = 92.8

CIPO Patents = 6 (Patent Applications = 8)

EPO Patents = 16 (Patent Applications = 28)

Average Co-Inventor Count = 4.6

ph-index = 21

Forward Citations = 1,004(Granted Patents)

Forward Citations (Not Self Cited) = 627(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

Incyte Holdings Corporation

patents

5 out of 234

Bristol-Myers Squibb Pharma Company

patents

4. 1 out of 3,736

Bristol-Myers Squibb Compnay

patents

5. 1 out of 106

Dupont Pharmaceuticals Company

patents

where one patent can have more than one assignee

Years Active: 2001-2026

Loading Chart...

Areas of Expertise:

PI3K Inhibitors

Tertiary Alcohols

Tricyclic Urea Compounds

Heterocyclic Compounds

Aminopyrazine Derivatives

Indoleamine Inhibitors

Pyrazolopyrimidine Derivatives

JAK2 Inhibitors

Substituted Imidazoles

Heterocyclylamines

Oxadiazoles

BET Protein Inhibitors

69 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12516065 - Tertiary alcohols as PI3K-γ inhibitors (2026-01-06),

2. 12421197 - Aminopyrazine derivatives as PI3K-γ inhibitors (2025-09-23),

3. 12201636 - Heterocyclylamines as PI3K inhibitors (2025-01-21),

4. 12187725 - Tricyclic urea compounds as JAK2 V617F inhibitors (2025-01-07),

5. 12173006 - Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor (2024-12-24),

6. 12152033 - Use of pyrazolopyrimidine derivatives for the treatment of PI3K-δ related disorders (2024-11-26),

7. 12084430 - Tricyclic urea compounds as JAK2 V617F inhibitors (2024-09-10),

8. 12030885 - Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors (2024-07-09),

9. 11958861 - Spirocyclic lactams as JAK2 V617F inhibitors (2024-04-16),

10. 11926630 - Tertiary alcohols as PI3K-γ inhibitors (2024-03-12),

11. 11819505 - Heterocyclylamines as PI3K inhibitors (2023-11-21),

12. 11780840 - Tricyclic urea compounds as JAK2 V617F inhibitors (2023-10-10),

13. 11773102 - Heterocyclic compounds as PI3K-γ inhibitors (2023-10-03),

14. 11661422 - Tricyclic urea compounds as JAK2 V617F inhibitors (2023-05-30),

15. 11433071 - Heterocyclylamines as PI3K inhibitors (2022-09-06),

Title: The Inventor Profile of Eddy W Yue

Introduction: Eddy W Yue is a distinguished inventor based in Landenberg, Pennsylvania. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to the field of technology through his inventive spirit.

Latest Patents: Eddy W Yue holds several patents in various technological domains, showcasing his versatility and creativity in inventing novel solutions to complex challenges.

Career Highlights: Throughout his career, Eddy W Yue has demonstrated a remarkable ability to translate ideas into tangible inventions. His innovative approach has led to the development of groundbreaking technologies that have had a lasting impact on the industry.

Collaborations: Eddy W Yue has collaborated with leading experts and organizations in the technology sector, fostering a culture of innovation and knowledge sharing. His collaborative efforts have resulted in the creation of cutting-edge solutions that have pushed the boundaries of what is possible.

Conclusion: Eddy W Yue's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His pioneering work continues to inspire future generations of inventors to think outside the box and create solutions that shape the future of technology.